ImmuCell Q3 Earnings Decline Y/Y, Sales Grow Amid Margin Challenges [Yahoo! Finance]
ImmuCell Corporation (ICCC)
US:NASDAQ Investor Relations:
immucell.com/investors
Company Research
Source: Yahoo! Finance
Over the past month, ICCC stock has seen a 0.3% decline against the S&P 500's 0.7% rise, highlighting relatively underwhelming performance amid broader market strength. The company reported third-quarter 2024 earnings per diluted share of 9 cents, down from 12 cents in the prior-year quarter. ImmuCell's product sales for the third quarter of 2024 increased 11% to $6 million from $5.4 million in the year-ago quarter. This growth reflects robust customer demand for the company's First Defense product line, particularly its expanded Tri-Shield offering. ImmuCell Corporation price-consensus-eps-surprise-chart | ImmuCell Corporation Quote ImmuCell faced continued challenges with production costs. The cost of goods sold increased to $4.4 million in the third quarter of 2024 from $4.1 million a year earlier, led by inflationary pressures on labor and raw materials. However, contamination events, which significantly affected the company's previous quarters, have not recurred since Apr
Show less
Read more
Impact Snapshot
Event Time:
ICCC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ICCC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ICCC alerts
High impacting ImmuCell Corporation news events
Weekly update
A roundup of the hottest topics
ICCC
News
- Zacks Initiates Coverage of ImmuCell With Neutral Recommendation [Yahoo! Finance]Yahoo! Finance
- ImmuCell Third Quarter 2024 Earnings: US$0.086 loss per share (vs US$0.12 loss in 3Q 2023) [Yahoo! Finance]Yahoo! Finance
- ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2024GlobeNewswire
- ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2024 [Yahoo! Finance]Yahoo! Finance
- ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2024GlobeNewswire
ICCC
Sec Filings
- 12/9/24 - Form 8-K
- 12/2/24 - Form 8-K
- 11/13/24 - Form 10-Q
- ICCC's page on the SEC website